Skip to search formSkip to main contentSkip to account menu

590-S

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

1-phthalidyl-5-fluorouracil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
[A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
A phase II clinical study involving 16 institutions was performed for the treatment of breast cancer with 590-S, a new masked… 
1987
1987
[Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
590-S is a new masked compound of 5-fluorouracil, the antimetabolic antitumor agent of the fluorinated pyrimidine group. The safe… 
1986
1986
[Pharmacokinetic studies of a new fluorinated pyrimidine, 590-S (PH-FU), in human patients].
590-S (PH-FU) has a chemical structure of 1-(3-oxo-1, 3-dihydro-1-isobenzofranyl)-5-fluorouracil, which belongs to the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)